EU lifted ban imposed on drug exports from Ranbaxy’s Toansa Plant

Ban imposed on export of drugs produced in Ranbaxy’s Toansa plant was lifted by the European health regulator...

Created On: Jun 6, 2014 17:33 ISTModified On: Jun 6, 2014 17:37 IST

The European health regulator on 5 June 2014 lifted suspension imposed on export of drugs produced at the Ranbaxy’s Toansa plant in Punjab in India. The imposed ban was lifted by terming that the medicines produced at the site don’t pose any threat to public health despite having number of manufacturing deficiencies.

The European Medicines Agency (EMA) announced that assessment of reported non-compliance with Good Manufacturing Practice (GMP) at Ranbaxy Laboratories at Toansa, India has been finalised by the European regulatory authorities. The assessment showed a number of GMP deficiencies at the concerned site, but doesn’t pose any threat to public health.

Based on the assessment report of the regulatory authorities, the GMP certificate of the plant will be reinstated which was suspended in January 2014 in European Union. The certificate will be re-entered into EudraGMDP, the EU database that contains GMP certificates.

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप

Comment ()

Post Comment

2 + 9 =